Articles
Volume 8 Supplement 2
Breast cancer research: the past and the future
- Meeting abstracts
- from Breast cancer research: the past and the future
- London, UK
- 1 November 2006
|
Breast cancer susceptibility after BRCA1/2: finding the genes and potential practical applications BAJ Ponder, AM Dunning, DF Easton, PDP Pharoah Breast Cancer Research 2006, 8(Suppl 2):S1 (1 November 2006) |
|
Translating breast cancer research into clinical practice — new approaches and better outcomes SRD Johnston Breast Cancer Research 2006, 8(Suppl 2):S2 (1 November 2006) |
|
Evolution of aromatase inhibitors as an endocrine treatment for breast cancer WR Miller Breast Cancer Research 2006, 8(Suppl 2):S3 (1 November 2006) |
|
BRCA1 transcriptionally regulates genes associated with the basal breast cancer phenotype JE Quinn, CR James, JJ Gorskii, PB Mullan, DP Harkin Breast Cancer Research 2006, 8(Suppl 2):S4 (1 November 2006) |
|
Regulation of recombinational repair by the familial breast cancer susceptibility protein BRCA2 SC West, F Esashi Breast Cancer Research 2006, 8(Suppl 2):S5 (1 November 2006) |
|
Chromosome translocations may play a significant role in breast cancer KL Howarth, KA Blood, JC Pole, SL Cooke, Y-L Chua, JC Beavis, B-L Ng, PAW Edwards Breast Cancer Research 2006, 8(Suppl 2):S6 (1 November 2006) |
|
Regulation of human breast stem cells RB Clarke Breast Cancer Research 2006, 8(Suppl 2):S7 (1 November 2006) |
|
Aberrant activation of Notch signalling in human breast cancer S Stylianou, GM Collu, RB Clarke, K Brennan Breast Cancer Research 2006, 8(Suppl 2):S8 (1 November 2006) |
|
Novel roles for integrins in tumour angiogenesis M Germain, R Silva, L Reynolds, S Robinson, M DiPersio, J Kreidberg, E Georges-Labouesse, K Hodivala-Dilke Breast Cancer Research 2006, 8(Suppl 2):S9 (1 November 2006) |
|
Genome-wide RNAi to identify genes that confer synthetic lethality with BRCA1 MIR Petalcorin, JS Martin, SJ Boulton Breast Cancer Research 2006, 8(Suppl 2):S10 (1 November 2006) |
|
Microarray studies reveal novel genes associated with endocrine resistance in breast cancer RS Burmi, RA McClelland, D Barrow, IO Ellis, JFR Robertson, RI Nicholson, JMW Gee Breast Cancer Research 2006, 8(Suppl 2):S11 (1 November 2006) |
|
Benefits of combined treatments using antiresorptive agents and cytotoxic drugs I Holen, H Neville-Webbe, RE Coleman Breast Cancer Research 2006, 8(Suppl 2):S12 (1 November 2006) |
|
L Bergman, J Blaydes Breast Cancer Research 2006, 8(Suppl 2):P1 (1 November 2006) |
|
Phenotypic characterization of mouse mammary epithelial stem and progenitor cells J Stingl, CJ Eaves, CJ Watson Breast Cancer Research 2006, 8(Suppl 2):P2 (1 November 2006) |
|
Characterisation of the tumour suppressor gene EM Valleley, SF Cordery, M Shires, V Speirs, DT Bonthron Breast Cancer Research 2006, 8(Suppl 2):P3 (1 November 2006) |
|
Role of BRCT motif containing proteins in Chk1 activation RG Beniston, CGW Smythe Breast Cancer Research 2006, 8(Suppl 2):P4 (1 November 2006) |
|
The YL Chua, PAW Edwards Breast Cancer Research 2006, 8(Suppl 2):P5 (1 November 2006) |
|
hCLK2 couples FANCD2 to stalled replication forks and functions in the mammalian S-phase checkpoint SJ Collis, LJ Barber, JS Martin, JD Ward, SJ Boulton Breast Cancer Research 2006, 8(Suppl 2):P6 (1 November 2006) |
|
Poly(ADPribosyl)ation of CTCF: role in breast tumourigenesis F Docquier, D Farrar, I Chernukhin, E Klenova Breast Cancer Research 2006, 8(Suppl 2):P7 (1 November 2006) |
|
Investigating the role of Wnt signalling in lobuloalveolar development of the mammary gland RJ Evans, C Dale Breast Cancer Research 2006, 8(Suppl 2):P8 (1 November 2006) |
|
Inhibitor of apoptosis proteins in breast cancer FM Foster, CH Streuli Breast Cancer Research 2006, 8(Suppl 2):P9 (1 November 2006) |
|
A Fourtouna, E Murray, L Hayward, L Pohler, T Hupp Breast Cancer Research 2006, 8(Suppl 2):P10 (1 November 2006) |
|
Role of CASP8 D302H and other apoptosis gene variants in breast cancer SH Mistry, S Rafii, AL Shippen, G MacPherson, S Balasubramanian, MW Reed, A Cox Breast Cancer Research 2006, 8(Suppl 2):P11 (1 November 2006) |
|
Functional analysis of the breast cancer associated transcriptional repressor PLU-1/JARID1B J Taylor-Papadimitriou, A Barrett, S Santangelo, S Catchpole, J Coleman, D Hall, J Burchell, AG Scibetta Breast Cancer Research 2006, 8(Suppl 2):P12 (1 November 2006) |
|
Potential role of cyclin D1 in DNA damage response N Suwaki, DJ Mann Breast Cancer Research 2006, 8(Suppl 2):P13 (1 November 2006) |
|
Functional analysis of normal and DCIS modified breast myoepithelial cells M Allen, K Mulligan, S Clark, I Hart, JF Marshall, JL Jones Breast Cancer Research 2006, 8(Suppl 2):P14 (1 November 2006) |
|
AGR2, a novel metastasis inducing protein with an effect on breast cancer patient survival DL Barraclough, H Innes, S Taylor, MPA Davies, A Platt-Higgins, DR Sibson, PS Rudland, R Barraclough Breast Cancer Research 2006, 8(Suppl 2):P15 (1 November 2006) |
|
Insulin-like growth factor signalling in oestrogen nonresponsive breast cancer cells GE de Blaquiere, FEB May, BR Westley Breast Cancer Research 2006, 8(Suppl 2):P16 (1 November 2006) |
|
Role of the Brk tyrosine kinase in breast cancer progression AJ Harvey, W Court, G Box, SA Eccles, MR Crompton Breast Cancer Research 2006, 8(Suppl 2):P17 (1 November 2006) |
|
The emerging role of CD44 in regulating skeletal metastasis A Hill, S McFarlane, PG Johnston, DJJ Waugh Breast Cancer Research 2006, 8(Suppl 2):P18 (1 November 2006) |
|
Evaluation of migration-stimulating factor expression for breast cancer diagnosis and prognosis SJ Jones, IR Ellis, K Kankova, AM Thompson, P Preece, S Kazmi, SL Schor, AM Schor Breast Cancer Research 2006, 8(Suppl 2):P19 (1 November 2006) |
|
Functional analysis of altered Tenascin isoform expression in breast cancer RA Alcock, JH Pringle, JA Shaw, DL Holliday, M Allen, RA Walker, JL Jones Breast Cancer Research 2006, 8(Suppl 2):P20 (1 November 2006) |
|
E Odintsova, F Berditchevski Breast Cancer Research 2006, 8(Suppl 2):P21 (1 November 2006) |
|
Expression of adrenomedullin in long-term oestrogen-deprived human breast cancer cells A Sadler, P Darbre Breast Cancer Research 2006, 8(Suppl 2):P22 (1 November 2006) |
|
Role of protein kinase B in breast cancer EM Sale, CP Hodgkinson, NP Jones, GJ Sale Breast Cancer Research 2006, 8(Suppl 2):P23 (1 November 2006) |
|
Progress towards unlocking the secrets of oestrogen receptor beta in breast cancer V Speirs, MD Parker, AR Green, IO Ellis, AM Hanby, PTK Saunders, AM Shaaban Breast Cancer Research 2006, 8(Suppl 2):P24 (1 November 2006) |
|
New molecular tools and optical technologies to dissect CXCR4 function in breast cancer PW Thavasu, F Festy, R Springall, K Ryder, R Waters, M Kelleher, S Pinder, C Gillett, T Ng Breast Cancer Research 2006, 8(Suppl 2):P25 (1 November 2006) |
|
T Friedberg, E Polson, S Weidlich Breast Cancer Research 2006, 8(Suppl 2):P26 (1 November 2006) |
|
D Eccles, S Gerty, P Simmonds Breast Cancer Research 2006, 8(Suppl 2):P27 (1 November 2006) |
|
S Scollen, AM Dunning, R Hesketh, JC Metcalfe Breast Cancer Research 2006, 8(Suppl 2):P28 (1 November 2006) |
|
M Harvie, M Chapman, J Cuzick, A Flyvbjerg, P Hopwood, S Jebb, G Parfitt, A Howell Breast Cancer Research 2006, 8(Suppl 2):P29 (1 November 2006) |
|
AU Lokugamage, M Hotopf, R Hardy, G Mishra, S Butterworth, MEJ Wadsworth, D Kuh Breast Cancer Research 2006, 8(Suppl 2):P30 (1 November 2006) |
|
GJ Bates, SB Fox, C Han, RD Leek, JF Garcia, AL Harris, AH Banham Breast Cancer Research 2006, 8(Suppl 2):P31 (1 November 2006) |
|
Development of anti-MUC1 DNA aptamers for the imaging and radiotherapy of breast cancer C Da Pieve, JN Iley, A Perkins, S Missailidis Breast Cancer Research 2006, 8(Suppl 2):P32 (1 November 2006) |
|
Global histone modifications in breast cancer and their prognostic significance AR Green, S El-Shiekh, EA Rakha, EC Paish, DM Heery, IO Ellis Breast Cancer Research 2006, 8(Suppl 2):P33 (1 November 2006) |
|
The Cambridge breast intensity modulated radiotherapy trial CE Coles, JS Wilkinson, AM Moody, ACF Hoole, N Twyman, NG Burnet Breast Cancer Research 2006, 8(Suppl 2):P34 (1 November 2006) |
|
Why do most c-erbB-2/HER-2-positive breast cancer patients fail to respond to Herceptin? ML Murphy, SKW Chan, L Bazley, NVL Hayes, WJ Gullick Breast Cancer Research 2006, 8(Suppl 2):P35 (1 November 2006) |
|
Synergistic effects of cytotoxic drugs and antiresorptive agents PD Ottewell, M Jones, RE Coleman, I Holen Breast Cancer Research 2006, 8(Suppl 2):P36 (1 November 2006) |
|
Development of small-molecule transforming growth factor beta antagonists DJ Warner, RB Sessions, D Dawbarn, SS Prime, SJ Allen, IC Paterson Breast Cancer Research 2006, 8(Suppl 2):P37 (1 November 2006) |
|
Development of breast cancer immunotherapy using MUC1 retargeted T lymphocytes S Wilkie, MK Brenner, J Taylor-Papadimitriou, J Burchell, J Maher Breast Cancer Research 2006, 8(Suppl 2):P38 (1 November 2006) |
|
Effects of combined treatment with Zometa and Taxol on endothelial cells M Michailidou, N Brown, RE Coleman, I Holen Breast Cancer Research 2006, 8(Suppl 2):P39 (1 November 2006) |
|
Breast cancer follow-up: a focus group and interview study CA Hughes, J Connolley Breast Cancer Research 2006, 8(Suppl 2):P40 (1 November 2006) |
|
F Kennedy, D Harcourt, N Rumsey Breast Cancer Research 2006, 8(Suppl 2):P41 (1 November 2006) |
|
Setting a lower risk threshold for surveillance within breast cancer family services R Black, A Fordyce, M Reis, D Goudie, L McLeish, H Carnaghan, E Anderson, J Campbell, H Gregor, E Smyth, R Davidson, M Steel Breast Cancer Research 2006, 8(Suppl 2):P42 (1 November 2006) |
|
Role of macrophages in breast cancer angiogenesis NJ Brown, L Bingle, MWR Reed, CE Lewis Breast Cancer Research 2006, 8(Suppl 2):P43 (1 November 2006) |
|
Is transforming growth factor beta signalling required for breast cancer metastatic cell motility? S Giampieri, E Sahai Breast Cancer Research 2006, 8(Suppl 2):P44 (1 November 2006) |